These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10575921)

  • 1. [Hyperhomocysteinemia in chronic renal failure].
    Sydor A; Sułowicz W
    Przegl Lek; 1999; 56(7-8):520-4. PubMed ID: 10575921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
    Righetti M; Ferrario GM; Milani S; Serbelloni P; La Rosa L; Uccellini M; Sessa A
    Med Sci Monit; 2003 Apr; 9(4):PI19-24. PubMed ID: 12709680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
    Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
    Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of homocysteinemia measurement in chronic renal failure].
    Cabarkapa V; Stosić Z; Zeravica R; Ilincić B
    Med Pregl; 2007; 60 Suppl 2():81-3. PubMed ID: 18928165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can the cardiac death rate be reduced in dialysis patients?
    Avram MM
    Semin Dial; 2002; 15(1):26-9. PubMed ID: 11874588
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
    Perna AF; Capasso R; Acanfora F; Satta E; Lombardi C; Ingrosso D; Violetti E; Romano MM; De Santo NG
    Semin Nephrol; 2006 Jan; 26(1):20-3. PubMed ID: 16412820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a reversal of reverse epidemiology in renal transplant recipients?
    Chavalitdhamrong D; Danovitch GM; Bunnapradist S
    Semin Dial; 2007; 20(6):544-8. PubMed ID: 17991202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperhomocysteinemia as a risk factor for cardiovascular diseases in patients with chronic renal failure].
    Małecki R
    Pol Arch Med Wewn; 2000 Oct; 104(4):695-701. PubMed ID: 11392158
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
    Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of hyperhomocysteinemia in chronic kidney disease.
    Massy ZA
    Semin Nephrol; 2006 Jan; 26(1):24-7. PubMed ID: 16412821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia in end-stage renal failure.
    Kes P
    Acta Med Croatica; 2000; 54(4-5):175-81. PubMed ID: 11379482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.